DOK7 and breast carcinoma: Similarly, higher levels of DOK7 had better distant metastasis-free survival (DMFS) than those with low DOK7 expression (P < 0.0001) in 664 breast cancer patients (333 samples in low levels of DOK7 and 331 samples in high levels of DOK7) (Figure 2(c)).